Synthetic Biology Technology Market Set for Strong Expansion, Projected to Hit US$ 4.45 Billion by 2031 at 14.0% CAGR

QY Research has recently published a report, titled "Synthetic Biology Technology Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". The global Synthetic Biology Technology market is comprehensively analyzed in the report with the main objective of providing accurate market data and useful recommendations to help players to gain strong growth in future. The report is compiled by subject matter experts and experienced market analysts, which makes it highly authentic and reliable. Readers are provided with deep analysis of historical and future market scenarios to get sound understanding of market competition and other important aspects. The report offers exhaustive research on market dynamics, key segments, leading players, and different regional markets. It is a complete package of thorough analysis and research on the global Synthetic Biology Technology market.

The global market for Synthetic Biology Technology was estimated to be worth US$ 1736 million in 2024 and is forecast to a readjusted size of US$ 4447 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/medical-care-synthetic-biology-technology-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The strategic pursuit of sustainable alternatives, precision medicines, and biological manufacturing by industry and governments is accelerating the industrialization of synthetic biology. Corporate filings show that leading companies are positioning synthetic biology as a long-term growth driver, enhancing platform capabilities, automation, and partner ecosystems to increase delivery speed and product breadth; meanwhile, national engineering biology strategies and public research funding reduce commercialization uncertainty and channel capital and industry resources into the field.

Technological advances-lowering costs in DNA synthesis and high-throughput screening and embedding AI and automation into the DBTL cycle-shorten the pathway from concept to scalable product, offering visible strategic value and profit potential to CEOs, marketers, and investors.Commercial deployment of synthetic biology faces regulatory, ethical, and biosafety challenges: inconsistent cross-border governance of biological data and samples, evolving gene-editing regulations, and the social sensitivity of high-risk biological work demand greater investments in compliance and transparency. Platform strategies also create technical and capital barriers, making scale-up and market entry difficult for smaller innovators.

Moreover, scale-up uncertainties, environmental and ethical controversies, and systemic risks must be weighed by investors and boards when shaping strategic initiatives. End markets are shifting from single-point technology purchases toward platformized, customized services: pharma companies and CROs prefer deep partnerships with providers that offer end-to-end DBTL and scalable manufacturing to compress timelines to clinic; agriculture, materials, and energy sectors seek bio-manufactured alternatives to fossil feedstocks and favor platforms with proven scale-up performance. Concurrently, demand is rising for verifiable compliance, product traceability, and supply-chain resilience-advantages that integrated "technology + manufacturing + compliance" vendors can leverage to win large customers and long-term contracts.

Drivers and Restraints-

The report explains the drivers shaping the future of the Synthetic Biology Technology market. It evaluates the various forces that are expected to create a positive influence on the overall market. Analysts have studied the investments in research and development of products and technologies that are expected to give the players a definite boost. Furthermore, researchers have also included an analysis of the changing consumer behavior that is projected to impact the supply and demand cycles present in the global Synthetic Biology Technology market. Evolving per capita earnings, improving economic statuses, and emerging trends have all been studied in this research report.

The research report also explains the potential restraints present in the global Synthetic Biology Technology market. It evaluates the aspects that are likely to hamper the market growth in the near future. In addition to this assessment, it also provides a list of opportunities that could prove lucrative to the overall market. Analysts provide solutions for turning threats and restraints into successful opportunities in the coming years.

The competitive landscape of the global Synthetic Biology Technology market is broadly studied in the report with large focus on recent developments, future plans of top players, and key growth strategies adopted by them. The analysts authoring the report have profiled almost every major player of the global Synthetic Biology Technology market and thrown light on their crucial business aspects such as production, areas of operation, and product portfolio. All companies analyzed in the report are studied on the basis of vital factors such as market share, market growth, company size, production volume, revenue, and earnings.

Key Players Mentioned in the Global Synthetic Biology Technology Market Research Report:

Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
Ginkgo Bioworks
Agilent

The report offers great insights into important segments of the global Synthetic Biology Technology market while concentrating on their CAGR, market size, market share, and future growth potential. The global Synthetic Biology Technology market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Synthetic Biology Technology market.

Details of Synthetic Biology Technology Market Segmentation: -

Segment by Type:

Gene Synthesis
Oligonucleotide Synthesis
Bioinformatics Analysis
DNA Assembly

Segment by Application:

Medicine
Chemical Industry
Agriculture
Other

Research Methodology

This report has been compiled using latest primary and secondary research methodologies such as data triangulation, qualitative and quantitative analysis, and top-down and bottom-up approaches. The researchers also referred to reliable secondary sources for collecting important data and statistics. All the findings of the research study have been verified and revalidated with the help of authentic primary sources.

The researchers create a unique model and customize it for each research study. Their market forecasts are based on the industry-best combination of domain expertise, industry knowledge and experience, technological analysis, and economic tools. Technological market models are generally adopted for long-term market forecasting, whereas econometric models are adopted for short-term forecasting. The researchers were provided with advanced analysis tools at the time of the preparation of the report.

Report Objectives

(1) To carefully analyze and estimate the size of the global Synthetic Biology Technology market

(2) To clearly segment the global Synthetic Biology Technology market and estimate the market size of the segments

(3) To provide details about key strategies adopted by leading players of the global Synthetic Biology Technology market

(4) To help readers understand current and future market scenarios

(5) To provide information about latest trends of the global Synthetic Biology Technology market and its key segments

(6) To assess the contribution of each region or country to the global Synthetic Biology Technology market

(7) To provide information on important drivers, restraints, and opportunities of the global Synthetic Biology Technology market

(8) To accurately calculate the market shares of key segments, regions, and companies in the global Synthetic Biology Technology market

Request Pre-Order Enquiry or Customized Research on This Report: https://www.qyresearch.in/pre-order-inquiry/medical-care-synthetic-biology-technology-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Table of Content

1 Market Overview
1.1 Synthetic Biology Technology Product Introduction
1.2 Global Synthetic Biology Technology Market Size Forecast (2020-2031)
1.3 Synthetic Biology Technology Market Trends & Drivers
1.3.1 Synthetic Biology Technology Industry Trends
1.3.2 Synthetic Biology Technology Market Drivers & Opportunity
1.3.3 Synthetic Biology Technology Market Challenges
1.3.4 Synthetic Biology Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global Synthetic Biology Technology Players Revenue Ranking (2024)
2.2 Global Synthetic Biology Technology Revenue by Company (2020-2025)
2.3 Key Companies Synthetic Biology Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Synthetic Biology Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Synthetic Biology Technology
2.6 Synthetic Biology Technology Market Competitive Analysis
2.6.1 Synthetic Biology Technology Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Synthetic Biology Technology Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Biology Technology as of 2024)
2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gene Synthesis
3.1.2 Oligonucleotide Synthesis
3.1.3 Bioinformatics Analysis
3.1.4 DNA Assembly
3.2 Global Synthetic Biology Technology Sales Value by Type
3.2.1 Global Synthetic Biology Technology Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Synthetic Biology Technology Sales Value, by Type (2020-2031)
3.2.3 Global Synthetic Biology Technology Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Chemical Industry
4.1.3 Agriculture
4.1.4 Other
4.2 Global Synthetic Biology Technology Sales Value by Application
4.2.1 Global Synthetic Biology Technology Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Synthetic Biology Technology Sales Value, by Application (2020-2031)
4.2.3 Global Synthetic Biology Technology Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
5.1 Global Synthetic Biology Technology Sales Value by Region
5.1.1 Global Synthetic Biology Technology Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Synthetic Biology Technology Sales Value by Region (2020-2025)
5.1.3 Global Synthetic Biology Technology Sales Value by Region (2026-2031)
5.1.4 Global Synthetic Biology Technology Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Synthetic Biology Technology Sales Value, 2020-2031
5.2.2 North America Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Synthetic Biology Technology Sales Value, 2020-2031
5.3.2 Europe Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Synthetic Biology Technology Sales Value, 2020-2031
5.4.2 Asia Pacific Synthetic Biology Technology Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Synthetic Biology Technology Sales Value, 2020-2031
5.5.2 South America Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Synthetic Biology Technology Sales Value, 2020-2031
5.6.2 Middle East & Africa Synthetic Biology Technology Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Synthetic Biology Technology Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Synthetic Biology Technology Sales Value, 2020-2031
6.3 United States
6.3.1 United States Synthetic Biology Technology Sales Value, 2020-2031
6.3.2 United States Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Synthetic Biology Technology Sales Value, 2020-2031
6.4.2 Europe Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Synthetic Biology Technology Sales Value, 2020-2031
6.5.2 China Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.5.3 China Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Synthetic Biology Technology Sales Value, 2020-2031
6.6.2 Japan Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Synthetic Biology Technology Sales Value, 2020-2031
6.7.2 South Korea Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Synthetic Biology Technology Sales Value, 2020-2031
6.8.2 Southeast Asia Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Synthetic Biology Technology Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Synthetic Biology Technology Sales Value, 2020-2031
6.9.2 India Synthetic Biology Technology Sales Value by Type (%), 2024 VS 2031
6.9.3 India Synthetic Biology Technology Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 Genescript
7.1.1 Genescript Profile
7.1.2 Genescript Main Business
7.1.3 Genescript Synthetic Biology Technology Products, Services and Solutions
7.1.4 Genescript Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.1.5 Genescript Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Synthetic Biology Technology Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 IDT
7.3.1 IDT Profile
7.3.2 IDT Main Business
7.3.3 IDT Synthetic Biology Technology Products, Services and Solutions
7.3.4 IDT Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.3.5 IDT Recent Developments
7.4 Eurofins Genomics
7.4.1 Eurofins Genomics Profile
7.4.2 Eurofins Genomics Main Business
7.4.3 Eurofins Genomics Synthetic Biology Technology Products, Services and Solutions
7.4.4 Eurofins Genomics Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.4.5 Eurofins Genomics Recent Developments
7.5 DNA 2.0 (ATUM)
7.5.1 DNA 2.0 (ATUM) Profile
7.5.2 DNA 2.0 (ATUM) Main Business
7.5.3 DNA 2.0 (ATUM) Synthetic Biology Technology Products, Services and Solutions
7.5.4 DNA 2.0 (ATUM) Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.5.5 DNA 2.0 (ATUM) Recent Developments
7.6 BBI
7.6.1 BBI Profile
7.6.2 BBI Main Business
7.6.3 BBI Synthetic Biology Technology Products, Services and Solutions
7.6.4 BBI Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.6.5 BBI Recent Developments
7.7 Azenta Life Sciences
7.7.1 Azenta Life Sciences Profile
7.7.2 Azenta Life Sciences Main Business
7.7.3 Azenta Life Sciences Synthetic Biology Technology Products, Services and Solutions
7.7.4 Azenta Life Sciences Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.7.5 Azenta Life Sciences Recent Developments
7.8 SBS Genetech
7.8.1 SBS Genetech Profile
7.8.2 SBS Genetech Main Business
7.8.3 SBS Genetech Synthetic Biology Technology Products, Services and Solutions
7.8.4 SBS Genetech Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.8.5 SBS Genetech Recent Developments
7.9 Bio Basic
7.9.1 Bio Basic Profile
7.9.2 Bio Basic Main Business
7.9.3 Bio Basic Synthetic Biology Technology Products, Services and Solutions
7.9.4 Bio Basic Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.9.5 Bio Basic Recent Developments
7.10 Twist Bioscience
7.10.1 Twist Bioscience Profile
7.10.2 Twist Bioscience Main Business
7.10.3 Twist Bioscience Synthetic Biology Technology Products, Services and Solutions
7.10.4 Twist Bioscience Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.10.5 Twist Bioscience Recent Developments
7.11 OriGene
7.11.1 OriGene Profile
7.11.2 OriGene Main Business
7.11.3 OriGene Synthetic Biology Technology Products, Services and Solutions
7.11.4 OriGene Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.11.5 OriGene Recent Developments
7.12 Bioneer
7.12.1 Bioneer Profile
7.12.2 Bioneer Main Business
7.12.3 Bioneer Synthetic Biology Technology Products, Services and Solutions
7.12.4 Bioneer Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.12.5 Bioneer Recent Developments
7.13 Eton Bioscience
7.13.1 Eton Bioscience Profile
7.13.2 Eton Bioscience Main Business
7.13.3 Eton Bioscience Synthetic Biology Technology Products, Services and Solutions
7.13.4 Eton Bioscience Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.13.5 Eton Bioscience Recent Developments
7.14 Synbio Technologies
7.14.1 Synbio Technologies Profile
7.14.2 Synbio Technologies Main Business
7.14.3 Synbio Technologies Synthetic Biology Technology Products, Services and Solutions
7.14.4 Synbio Technologies Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.14.5 Synbio Technologies Recent Developments
7.15 Eurogentec
7.15.1 Eurogentec Profile
7.15.2 Eurogentec Main Business
7.15.3 Eurogentec Synthetic Biology Technology Products, Services and Solutions
7.15.4 Eurogentec Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.15.5 Eurogentec Recent Developments
7.16 Ginkgo Bioworks
7.16.1 Ginkgo Bioworks Profile
7.16.2 Ginkgo Bioworks Main Business
7.16.3 Ginkgo Bioworks Synthetic Biology Technology Products, Services and Solutions
7.16.4 Ginkgo Bioworks Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.16.5 Ginkgo Bioworks Recent Developments
7.17 Agilent
7.17.1 Agilent Profile
7.17.2 Agilent Main Business
7.17.3 Agilent Synthetic Biology Technology Products, Services and Solutions
7.17.4 Agilent Synthetic Biology Technology Revenue (US$ Million) & (2020-2025)
7.17.5 Agilent Recent Developments

8 Industry Chain Analysis
8.1 Synthetic Biology Technology Industrial Chain
8.2 Synthetic Biology Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Synthetic Biology Technology Sales Model
8.5.2 Sales Channel
8.5.3 Synthetic Biology Technology Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

Contact US

Ankit Jain - Director, Global Digital Marketing

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Email- ankit@qyresearch.com

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

This release was published on openPR.